Target intelligence / Profile preview

Hepatitis B virus core protein (HBcAg) (HBcAg)

Target
HBcAg
Molecular classification
Viral structural protein, Capsid protein
01

Overview

The Hepatitis B virus core protein (HBcAg) is a vital structural component of the Hepatitis B virus (HBV) responsible for the assembly of the viral nucleocapsid [1]. This protein self-assembles into an icosahedral shell that encapsulates the viral pregenomic RNA (pgRNA) and the viral polymerase, a process essential for the subsequent reverse transcription of the viral genome [2]. Beyond its structural role, HBcAg is involved in the intracellular transport of the viral genome to the host cell nucleus and the regulation of the covalently closed circular DNA (cccDNA) reservoir [3]. In chronic hepatitis B infection, the core protein is a major therapeutic target for a class of antivirals known as Capsid Assembly Modulators (CAMs) or Core protein Allosteric Modulators (CpAMs) [4]. These drugs bind to the core protein dimers and interfere with the assembly process, leading to either the formation of non-functional protein aggregates or the production of empty, genome-deficient capsids [3,5]. By inhibiting proper nucleocapsid formation and genome packaging, these therapies aim to significantly reduce viral replication and the replenishment of the cccDNA pool, potentially leading to a functional cure [2,4].

Other names
Hepatitis B virus core proteinHBV core proteinHepatitis B virus capsid proteinHBcp21cHepatitis B Virus nucleocapsid incorporation / viral particle assembly
02

Mechanism of action

Allosteric modulation of capsid assembly (Class I: induction of aberrant polymers; Class II: induction of empty capsids)

03

Biological functions

Viral assemblyGenome packagingReverse transcriptionIntracellular traffickingNuclear signaling
04

Disease associations

InfectionChronic Hepatitis BHepatocellular carcinomaLiver cirrhosis
05

Safety considerations

ALT flares (hepatic flares)Viral resistance mutations (e.g., T109M, Y118F)Drug-drug interactions
06

Interacting drugs

Vebicorvir (ABI-H0731)

6 more in the full profile.

07

Biomarkers

HBV DNAHBV RNAHBcrAg (Hepatitis B core-related antigen)HBeAg

Beyond the preview

Go deeper on Hepatitis B virus core protein (HBcAg) (HBcAg).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B virus core protein (HBcAg) (HBcAg).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call